Liron Yitzhak, MA

Tel Aviv Sourasky Medica Center, Israel

Poster(s):

• 1903 - Hematopoietic Progenitor Kinase-1 (HPK-1) Inhibition Improves the In Vitro Efficacy of
  Bispecific Antibodies in CLL